Routine use of generative AI is taking hold in SANTEN PHARMACEUTICAL CO.,LTD.'s R&D department, with weekly usage reaching 93%. AI is being used to prepare clinical trial protocols and reports and to search meeting minutes, while documents equivalent to one truckload are also being digitized.
The use of generative AI is becoming part of daily operations in SANTEN PHARMACEUTICAL CO.,LTD.'s R&D department. Weekly usage is reported to have reached 93%.
AI is used to prepare clinical trial protocols and reports, and meeting minutes can now also be searched using AI, helping improve the efficiency of information gathering. The digitization of documents equivalent to one truckload is also reportedly under way.